3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
23
Phase 1/2
8
Phase 1
8
Phase 3
4
Phase NA
2
Phase 2/3
2
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Carcinoma, Non-Small-Cell Lung
3
Breast Neoplasms
3
Ovarian Neoplasms
2
Neuroblastoma
2
Endometrial Neoplasms
2
Turcot syndrome
1
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma
1
Rhabdoid Tumor
1
Pyloric Stenosis, Hypertrophic
1
Prostatic Neoplasms
1
Pinealoma
1
Pancreatic Neoplasms
1
Neuroectodermal Tumors, Primitive
1
Neoplasms
1
Muscle Invasive Bladder Urothelial Carcinoma
1
Medulloblastoma
1
Lymphoma, B-Cell
1
Head and Neck Neoplasms
1
Glioma
1
Fallopian Tube Neoplasms
1
EGFR Positive Non-small Cell Lung Cancer
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Brain Neoplasms
1
Interventions
Magnetic Resonance Spectroscopy
6
Temozolomide
3
Biopsy
3
Bevacizumab
3
posaconazole
2
fluciclovine F-18
2
Topotecan
2
Specimen Handling
2
Radiosurgery
2
Pemetrexed
2
Nivolumab
2
Methotrexate
2
Ketoconazole
2
Fluorodeoxyglucose F18
2
ribociclib
1
relatlimab
1
mycophenolic adenine dinucleotide
1
montelukast
1
gancotamab
1
fluoromisonidazole
1
fluorodopa F 18
1
fludarabine phosphate
1
etoposide phosphate
1
eribulin
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
clevudine
1
ceritinib
1
brivaracetam
1
auricularum
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase EARLY_PHASE1
×
Brain Neoplasms
×
Carboplatin
×
Clear all
NCT02279992
2017-09-11
LevitraCarbo
Cedars-Sinai Medical Center
Phase EARLY_PHASE1
Terminated
7 enrolled